Celsius Holdings, Inc. Reports Record Preliminary and Unaudited Fourth Quarter and Full Year 2021 Financial Results
Celsius Holdings, Inc. (Nasdaq: CELH) announced preliminary financial results for Q4 and the full year ended December 31, 2021. Despite reporting significant growth, including a $3,180,000 increase in share-based compensation for Q2 2021 and $12,116,000 for Q3 2021, the company faced challenges with staffing and material errors in prior filings. They filed for a 15-day extension for their Form 10-K, with future results subject to change.
Management has recognized weaknesses in internal controls and is taking steps to address these issues.
- Significant growth in preliminary financial results for Q4 and full year 2021.
- Celsius products are backed by six university studies validating health benefits.
- Material weaknesses were identified in internal controls over financial reporting.
- Errors in prior filings resulted in increased share-based compensation expenses, impacting reported figures.
BOCA RATON, Fla., March 1, 2022 /PRNewswire/ -- Celsius Holdings, Inc., (Nasdaq: CELH), maker of the leading global fitness drink, CELSIUS®, today reported preliminary and unaudited financial results for the fourth quarter and full year ended December 31, 2021. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss the results with the investment community.
A PDF containing our fourth quarter and full year preliminary and unaudited 2021 results and full financial tables is available at:
https://www.celsiusholdingsinc.com/Q4_2021
Although the Company has dedicated significant resources to the completion of finalizing its audited consolidated financial statements and related disclosures for inclusion in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and the required assessment of its internal controls over financial reporting as required by Section 404 of the Sarbanes-Oxley Act, the Company has encountered staffing limitations, unanticipated delays and identified material errors in previous filings as further described below. As a result, the Company has filed for the fifteen (15) day extension period provided under Rule 12b-25 and anticipates filing its Form 10-K including its audited financials prior to the expiration of the extension period. Accordingly, the fourth quarter and full year 2021 results set forth in the linked PDF are preliminary, unaudited and subject to change and adjustment.
In addition, as more fully described in the linked PDF, in connection with the preparation of its 2021, the Company determined that the calculation and expense of non-cash share-based compensation, related to grants of stock options and restricted stock units awarded to certain former employees and retired directors were materially understated for the three and six month periods ended June 30, 2021 and three and nine month periods ended September 30, 2021 and did not comply with U.S. GAAP. In order to correct previously reported non-cash share-based compensation during these periods, the Company is recognizing additional non-cash share-based compensation expense of approximately
The Company's management has concluded, however, that as a result of the above identified errors, a material weakness exists in the Company's internal controls over financial reporting related to the misapplication of U.S. GAAP in the Company's evaluation of modifications to share based payment arrangements and that the Company's disclosure controls and procedures were not effective as of December 31, 2021. The Company has taken remedial actions in this regard.
To participate in the conference call, please call one of the following telephone numbers at least 10 minutes before the start of the call:
US: 877-709-8150
International: 201-689-8354
An audio replay of the call will be available on the Company's website at:
https://www.celsiusholdingsinc.com/press-releases/
About Celsius Holdings, Inc.
Celsius Holdings, Inc. (Nasdaq: CELH), is a global company with a proprietary, clinically proven formula for its master brand CELSIUS® and all its sub-brands. A lifestyle fitness and supplement drink and a pioneer in the rapidly growing performance energy sector, CELSIUS® has five drink lines that each offer proprietary, functional, healthy-energy formulas clinically-proven to offer significant health benefits to its users. The five lines include, CELSIUS® Originals, CELSIUS HEAT™, CELSIUS® BCAA +Energy, CELSIUS® On-the-Go, and CELSIUS® Sweetened with Stevia. CELSIUS® has zero sugar, no preservatives, no aspartame, no high fructose corn syrup, and is non-GMO, with no artificial flavors or colors. The CELSIUS® line of products is Certified Kosher and Vegan. CELSIUS® is also soy and gluten-free and contains very little sodium. CELSIUS® is backed by six university studies that were published in peer-reviewed journals validating the unique benefits CELSIUS® provides. CELSIUS® is sold nationally at Target, CVS, Walmart, GNC, Vitamin Shoppe, 7-Eleven, Dick's Sporting Goods, The Fresh Market, Sprouts and other key regional retailers such as HEB, Publix, Winn-Dixie, Harris Teeter, Shaw's and Food Lion. It is also available on Amazon, at fitness clubs and in select micro-markets across the country. For more information, please visit:
http://www.celsiusholdingsinc.com
Forward-Looking Statements
Preliminary financial information, financial guidance and growth disclosure have been prepared by management based on information available to it as of the date hereof and should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. Estimated preliminary results are subject to completion of our customary quarterly and annual financial closing and audit and review procedures and are not comprehensive statements of our financial results for the three months and fiscal year ended December 31, 2021 and are subject to adjustments as a result of such procedures.
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements contain projections of Celsius Holdings' future results of operations and/or financial position, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "will," "would," or similar words. You should not rely on forward-looking statements since Celsius Holdings' actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include but are not limited to: general economic and business conditions; our business strategy for expanding our presence in our industry; anticipated trends in our financial condition and results of operation; the impact of competition and technology change; existing and future regulations affecting our business; the Company's ability to satisfy in a timely manner, all Securities and Exchange Commission (SEC) required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; and other risks and uncertainties discussed in the reports Celsius Holdings has filed previously with the Securities and Exchange Commission. Celsius Holdings does not intend to and undertakes no duty to update the information contained in this press release.
Investor Relations:
Cameron Donahue
(651) 707-3532
cdonahue@celsius.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/celsius-holdings-inc-reports-record-preliminary-and-unaudited-fourth-quarter-and-full-year-2021-financial-results-301493270.html
SOURCE Celsius Holdings, Inc.
FAQ
What were Celsius Holdings' preliminary financial results for Q4 2021?
What challenges did Celsius Holdings face in their financial reporting?
What is the stock symbol for Celsius Holdings?
When will Celsius Holdings file their audited financial statements?
What is the impact of the reported errors on Celsius Holdings' financials?
